Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Encompass Health Corporation (EHC : NYSE)

• Company Description    Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. Number of Employees: 40,000

• Price / Volume Information    Yesterday's Closing Price: $118.43 Daily Weekly Monthly 20 Day Moving Average: 683,660 shares Shares Outstanding: 100.80 (millions) Market Capitalization: $11,937.38 (millions) Beta: 0.88 52 Week High: $123.13 52 Week Low: $82.74 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -2.06% -6.48% 12 Week 14.59% -3.29% Year To Date 28.24% 20.49%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 9001 LIBERTY PARKWAY - BIRMINGHAM,AL 35242 USA ph: 205-967-7116 fax: 205-969-4719 mark.miller@encompasshealth.com http://www.encompasshealth.com

• General Corporate Information    Officers Mark J. Tarr - President and Chief Executive Officer Greg D. Carmichael - Chairman Douglas E. Coltharp - Executive Vice President and Chief Financial Offic Edward M. Christie - Director Joan E. Herman - Director Peer Information Encompass Health Corporation (CMTI) Encompass Health Corporation (CMWLQ) Encompass Health Corporation (AHG.) Encompass Health Corporation (ROIX) Encompass Health Corporation (M.DCE) Encompass Health Corporation (DHSM) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-OUTP/HM CRE Sector: Medical CUSIP: 29261A100 SIC: 8060 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/04/25 Share - Related Items Shares Outstanding: 100.80 Most Recent Split Date: 10.00 (0.20:1) Beta: 0.88 Market Capitalization: $11,937.38 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.57% Current Fiscal Quarter EPS Consensus Estimate: $1.15 Indicated Annual Dividend: $0.68 Current Fiscal Year EPS Consensus Estimate: $5.01 Payout Ratio: 0.15 Number of Estimates in the Fiscal Year Consensus: 8.00 Change In Payout Ratio: -0.09 Estmated Long-Term EPS Growth Rate: 9.83% Last Dividend Paid: 07/01/2025 - $0.17 Next EPS Report Date: 08/04/25

• Fundamental Ratios P/E Current FY Estimate: 23.64 Trailing 12 Months: 25.31 PEG Ratio: 2.41 Price Ratios Price/Book: 4.14 Price/Cash Flow: 15.67 Price / Sales: 2.17 EPS Growth vs. Year Ago Period: 22.32% vs. Previous Quarter: 17.09% Sales Growth vs. Year Ago Period: 10.59% vs. Previous Quarter: 3.59% ROE 06/30/25 - - 03/31/25 - 17.63 12/31/24 - 17.56 ROA 06/30/25 - - 03/31/25 - 7.33 12/31/24 - 7.06 Current Ratio 06/30/25 - - 03/31/25 - 1.06 12/31/24 - 1.05 Quick Ratio 06/30/25 - - 03/31/25 - 1.06 12/31/24 - 1.05 Operating Margin 06/30/25 - - 03/31/25 - 8.65 12/31/24 - 8.42 Net Margin 06/30/25 - - 03/31/25 - 8.97 12/31/24 - 8.48 Pre-Tax Margin 06/30/25 - - 03/31/25 - 14.69 12/31/24 - 13.95 Book Value 06/30/25 - - 03/31/25 - 28.59 12/31/24 - 27.72 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.81 12/31/24 - 0.84 Debt-to-Capital 06/30/25 - - 03/31/25 - 45.33 12/31/24 - 46.38

Powered by Zacks Investment Research ©